Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
This is the first study to directly demonstrate reduced GABA receptor availability in human FXS patients, supporting the hypothesis that GABA receptors could be a potential target for FXS drug therapy (128)
Damaged or improperly stored vial
MarkovKPleadinJBevardiMVahiNSokoli-MihalakDFreceJ
This makes it an excellent choice for patients who: This program also includes: Program Cost: Starting at $399 (includes injections and comprehensive support) No
US$ 27.42
US$ 28.46
US$ 28.69
US$ 25.72
US$ 26.07
